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Promising Prognosticator or Water Under the Bridge?*Koen Nieman, MD, PHD, Adriaan Coenen, MDSEE PAGE 684O ver the past decade the value of cardiaccomputed tomography (CT) in the contextof acute chest pain and suspected myocar-
dial infarction has been intensively investigated. Cor-
onary CT angiography has high sensitivity for the
detection of coronary artery disease (CAD), and obser-
vational studies in chest pain cohorts have repeatedly
demonstrated that the absence of CAD conveys a very
low probability of acute coronary syndrome (ACS) and
is associated with an excellent clinical outcome (1–3).
Randomized controlled trials have conﬁrmed that in
patients with a low probability of ACS, cardiac CT is
a safe and reliable diagnostic option with potential
advantages in terms of efﬁciency and cost (4–6).
In addition, cardiac CT can identify myocardial
infarction. On coronary CT angiograms, myocardial in-
farction is characterized by reduced contrast enhan-
cement as a result of low perfusion. However,
differentiation of acute myocardial infarction from
chronic scar with fat tissue replacement can be difﬁcult.
Typically, fat tissue will have lower attenuation values
than areas of reduced perfusion, and defects will often
be visible on nonenhanced CT scans (calcium scans)
as well (7). Infarct detection by CT angiography appears
quite accurate in comparison to cardiac biomarkers or
other imaging techniques (8,9), although total infarct
size may be underestimated by CT compared with more
established infarct imaging techniques (10). The prog-
nostic value of infarct size has been investigated
using various techniques but not yet with cardiac CT.*Editorials published in JACC: Cardiovascular Imaging reﬂect the views of
the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
From the Departments of Cardiology and Radiology, Erasmus Medical
Center, Rotterdam, the Netherlands. Dr. Nieman is supported by a
grant from the Netherlands Heart Foundation; and has received
institutional research support from Siemens Medical Solutions, Bayer
Healthcare, and GE Healthcare. Dr. Coenen has reported that he has no
relationships relevant to the contents of this paper to disclose.In this issue of iJACC, Kühl et al. (11) investigated
the prognostic consequences of myocardial defects
detected on coronary CT angiograms in patients with
a non–ST-segment elevation myocardial infarction
(NSTEMI). The study cohort of nearly 400 individuals
was selected from a larger population of patients
presenting to the emergency department with acute
chest pain, for whom catheterization was considered
necessary but not urgently required. Contrast-
enhanced 64-detector cardiac CT was performed
before invasive angiography, although imaging re-
sults were withheld from the treating physicians. In
an elaborate analysis, the researchers applied variousparameters to characterize and quantify the presence,
size, and transmural extent of enhancement defects
of the myocardium. Of 376 evaluable patients, 62%
showed abnormal myocardial enhancement, of which
11% had evidence of chronic myocardial scar. The
combined endpoint of all-cause mortality and heart
failure–related hospital admission at 4 years was
reached by 15% of patients. After correction for
several clinical parameters, ventricular function, and
CAD severity, the attenuation ratio between the
endocardial and epicardial myocardium and the
segmental defect score, which combined the number
of involved segments and the quantitative transmural
severity, remained predictive of adverse outcome.
Even after segments with evidence of old myocardial
infarction on CT were removed, enhancement defects
remained a signiﬁcant predictor of clinical outcome.
The cohort is the largest of its kind, and the long
follow-up permitted assessment of hard endpoints.
Infarct size by various imaging techniques is associ-
ated with adverse outcome, although most prognostic
data have been derived from cohorts with larger (ST-
segment elevation) myocardial infarctions. In a study
of patients with acute chest pain, rest perfusion de-
fects by nuclear imagingwere similarly associatedwith
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696outcome, but independent value over left ventricular
ejection fraction could not be demonstrated (12).
Contrary to these observations, in the present study,
which included patients with NSTEMI at relatively low
risk, the investigators demonstrated that myocardial
enhancement defects provided incremental prog-
nostic value over left ventricular ejection fraction.
A question that emerges from the presented results
is whether the ﬁnding of prognostically relevant de-
fects affects clinical management and therapeutic
decisions in a meaningful way. Apart from the clinical
context and individual patient characteristics, imag-
ing can indeed provide various types of informa-
tion that are relevant for management decisions.
Myocardial contractility, inducible ischemia, and
potential for functional recovery (viability) are all
well-established parameters to guide revasculari-
zation decisions. Unfortunately, imaging of the
myocardium during the arterial phase of enhance-
ment, without induced hyperemia, will not provide
these parameters in an optimal manner. As the in-
vestigators demonstrated, left ventricular function
can be assessed using cardiac CT but is associated with
more radiation exposure. Because of that, for routine
coronary CT angiography, roentgen exposure is pref-
erably limited to a brief period of the heart cycle.
Enhancement defects on CT could represent either
severe but reversible ischemia amenable to revascu-
larization or permanently damaged myocardium, and
it is not easy to distinguish between them. In case of
myocardial infarction, the ﬁrst-pass enhancement
defects underestimate total infarct size, and the true
transmural extent may be difﬁcult to interpret, which
would be important to assess myocardial viability
in case of functional impairment. Not all chronicinfarctions show evident fat tissue replacement,
whereas, on the other hand, its observation does not
exclude the occurrence of a second ischemic insult.
In the setting of acute chest pain in the emergency
department, the role of cardiac CT is momentarily
limited to ruling out ACS in low- to intermediate-risk
patients, generally without initial electrocardio-
graphic or biochemical abnormalities. Although the
incidence of false-negative ﬁrst troponin assays has
decreased substantially with the introduction of high-
sensitivity assays, evidence of severe myocardial
ischemia on CT could expedite the performance of
invasive angiography and potentially improve
outcome. The high sensitivity of new troponin assays
comes at the expense of lower speciﬁcity and poten-
tial overdiagnosis of ACS in the emergency depart-
ment. Even in this cohort of clinically established
NSTEMI, 18% of patients did not have signiﬁcant
angiographic disease and 27% required no revascu-
larization. Because high-sensitivity troponin assays
appear to allow quick and reliable ruling out of ACS in
many patients, the future role of cardiac CT could
very well shift toward those patients with mildly
elevated marker levels and avoid further (invasive)
diagnostic procedures by excluding angiographic
coronary disease. In this scenario, a comprehensive
assessment of myocardial enhancement defects, as an
expression of severe ischemia or impending myocar-
dial infarction, could potentially play a valuable role.
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